{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:07:00Z","timestamp":1782306420074,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chemistry Central Journal"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1752-153x-7-78","type":"journal-article","created":{"date-parts":[[2013,4,27]],"date-time":"2013-04-27T12:14:16Z","timestamp":1367064856000},"source":"Crossref","is-referenced-by-count":42,"title":["Synthesis and biological evaluation of 1, 3-dihydroxyxanthone mannich base derivatives as anticholinesterase agents"],"prefix":"10.1186","volume":"7","author":[{"given":"Jiangke","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,27]]},"reference":[{"key":"620_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ana.410340312","volume":"34","author":"CI Wright","year":"1993","unstructured":"Wright CI, Geula C, Mesulam MM: Neuroglial cholinesterases in the normal brain and in Alzheimer\u2019s disease: Relationship to plaques, tangles and patterns of selective vulnerability. Ann Neurol. 1993, 34: 373-384. 10.1002\/ana.410340312.","journal-title":"Ann Neurol"},{"key":"620_CR2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/1196","volume":"19","author":"DL Price","year":"1998","unstructured":"Price DL, Sisodia SS, Borchelt DR: Alzheimer disease-when and why?. Nat Genet. 1998, 19: 314-316. 10.1038\/1196.","journal-title":"Nat Genet"},{"key":"620_CR3","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.lfs.2005.12.004","volume":"78","author":"Y Luo","year":"2006","unstructured":"Luo Y: Alzheimer\u2019s disease, the nematode Caenorhabditis elegans, and ginkgo biloba leaf extract. Life Sci. 2006, 78: 2066-2072. 10.1016\/j.lfs.2005.12.004.","journal-title":"Life Sci"},{"key":"620_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2174\/1568026024607526","volume":"2","author":"LF Lau","year":"2002","unstructured":"Lau LF, Schachter JB, Seymour PA, Sanner MA: Tau protein phosphorylation as a pherapeutic parget in Alzheimer\u2019s pisease. Curr Top Med Chem. 2002, 2: 395-415. 10.2174\/1568026024607526.","journal-title":"Curr Top Med Chem"},{"key":"620_CR5","doi-asserted-by":"publisher","first-page":"811","DOI":"10.2165\/00023210-200216120-00003","volume":"16","author":"PM Doraiswamy","year":"2002","unstructured":"Doraiswamy PM: Non-cholinergic strategies for treating and preventing Alzheimer\u2019s disease. CNS Drugs. 2002, 16: 811-824. 10.2165\/00023210-200216120-00003.","journal-title":"CNS Drugs"},{"key":"620_CR6","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.7046051","volume":"217","author":"RT Bartus","year":"1982","unstructured":"Bartus RT, Dean RL, Beer B, Lippa AS: The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982, 217: 408-417. 10.1126\/science.7046051.","journal-title":"Science"},{"key":"620_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1006\/exnr.2000.7397","volume":"163","author":"RT Bartus","year":"2000","unstructured":"Bartus RT: On neurodegenerative diseases, models and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol. 2000, 163: 495-529. 10.1006\/exnr.2000.7397.","journal-title":"Exp Neurol"},{"key":"620_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA: Alzheimer\u2019s disease: The amyloid cascade hypothesis. Science. 1992, 256: 184-185. 10.1126\/science.1566067.","journal-title":"Science"},{"key":"620_CR9","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1126\/science.7058341","volume":"211","author":"PJ Whitehouse","year":"1982","unstructured":"Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR: Alzheimer\u2019s disease and senile dementia: Loss of neurons in the basal forebrain. Science. 1982, 211: 1237-1239.","journal-title":"Science"},{"key":"620_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2174\/156720508786898514","volume":"5","author":"Y Ohyagi","year":"2008","unstructured":"Ohyagi Y: Intracellular Amyloid \u03b2-protein as a therapeutic target for treating Alzheimei\u2019s disease. Curr Alzheimer Res. 2008, 5: 555-561. 10.2174\/156720508786898514.","journal-title":"Curr Alzheimer Res"},{"key":"620_CR11","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.2174\/138161208786404137","volume":"14","author":"G Yamin","year":"2008","unstructured":"Yamin G, Ono K, Inayathullah M, Teplow DB: Amyloid \u03b2-protein assembly as a therapeutic target of Alzheimer\u2019s disease. Current Pharm Design. 2008, 14: 3231-3246. 10.2174\/138161208786404137.","journal-title":"Current Pharm Design"},{"key":"620_CR12","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","volume":"16","author":"NC Inestrosa","year":"1996","unstructured":"Inestrosa NC, Alvarez A, P\u00e9rez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J: Acetylcholinesterase accelerates assembly of amyloid-\u03b2-peptides into Alzheimer\u2019s fibrils: Possible role of the peripheral site of the enzyme. Neuron. 1996, 16: 881-891. 10.1016\/S0896-6273(00)80108-7.","journal-title":"Neuron"},{"key":"620_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1586\/14737175.5.1.101","volume":"5","author":"A Tasker","year":"2005","unstructured":"Tasker A, Perry EK, Ballard CG: Butyrylcholinesterase: Impact on symptoms and progression of cognitive impairment. Expert Rev Neurotherapeutics. 2005, 5: 101-106. 10.1586\/14737175.5.1.101.","journal-title":"Expert Rev Neurotherapeutics"},{"key":"620_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.bbr.2011.07.035","volume":"1","author":"Y Furukawa-Hibi","year":"2011","unstructured":"Furukawa-Hibi Y, Alkam T, Nitta A, Matsuyama A, Mizoguchi H, Suzuki K, Moussaoui S, Yu QS, Greig NH, Nagai T: Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-[beta] peptide in mice. Behav Brain Res. 2011, 1: 222-229.","journal-title":"Behav Brain Res"},{"key":"620_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/NEN.0b013e31823cc7a6","volume":"71","author":"S Darvesh","year":"2012","unstructured":"Darvesh S, Cash MK, Reid GA, Martin E, Mitnitski A, Geula C: Butyrylcholinesterase is associated with \u03b2-amyloid plaques in the transgenic APPSWE\/PSEN1dE9 mouse model of Alzheimer disease. J Neuropathol Exp Neurol. 2012, 71: 2-14. 10.1097\/NEN.0b013e31823cc7a6.","journal-title":"J Neuropathol Exp Neurol"},{"key":"620_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1365-2990.1978.tb00545.x","volume":"4","author":"EK Perry","year":"1978","unstructured":"Perry EK, Perry RH, Blessed G, Tomlinson BE: Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol. 1978, 4: 273-277. 10.1111\/j.1365-2990.1978.tb00545.x.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"620_CR17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.phrs.2003.11.017","volume":"50","author":"E Giacobini","year":"2004","unstructured":"Giacobini E: Cholinesterase inhibitors: New roles and therapeutic alternatives. Pharmacol Res. 2004, 50: 433-440. 10.1016\/j.phrs.2003.11.017.","journal-title":"Pharmacol Res"},{"key":"620_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1185\/03007990152673800","volume":"17","author":"NH Greig","year":"2001","unstructured":"Greig NH, Utsuki 1T, Yu QS, Zhu XX, Holloway HW, Perry TA, Lee B, Ingram DK, Lahiri DK: A new therapeutic target in Alzheimer\u2019s disease treatment: Attention to butyrylcholinesterase. Curr Med Res Opin. 2001, 17: 159-165.","journal-title":"Curr Med Res Opin"},{"key":"620_CR19","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.2174\/092986711797200435","volume":"18","author":"T Mohamed","year":"2011","unstructured":"Mohamed T, Rao PPN: Alzheimers disease: emerging trends in small molecule therapies. Curr Med Chem. 2011, 18: 4299-4320. 10.2174\/092986711797200435.","journal-title":"Curr Med Chem"},{"key":"620_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1211\/jpp.61.06.0002","volume":"61","author":"Y Na","year":"2009","unstructured":"Na Y: Recent cancer drug development with xanthone structures. J Pharm Pharmacol. 2009, 61: 707-712. 10.1211\/jpp.61.06.0002.","journal-title":"J Pharm Pharmacol"},{"key":"620_CR21","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.bmcl.2012.01.068","volume":"22","author":"XM Gao","year":"2012","unstructured":"Gao XM, Yu T, Cui MZ, Pu JX, Du X, Han QB, Hu QF, Liu TC, Luo KQ, Xu HX: Identification and evaluation of apoptotic compounds from Garcinia oligantha. Bioorg Med Che. Lett. 2012, 22: 2350-10.1016\/j.bmcl.2012.01.068.","journal-title":"Bioorg Med Che. Lett"},{"key":"620_CR22","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.2174\/092986705774370691","volume":"12","author":"MMM Pinto","year":"2005","unstructured":"Pinto MMM, Sousa ME, Nascimento MSJ: Xanthone derivatives: New insights in biological activities. Curr Med Chem. 2005, 12: 2517-2538. 10.2174\/092986705774370691.","journal-title":"Curr Med Chem"},{"key":"620_CR23","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1016\/j.ejmech.2011.06.003","volume":"46","author":"GL Li","year":"2011","unstructured":"Li GL, He JY, Zhang AQ, Wan YQ, Wang B, Chen WH: Toward potent \u03b1-glucosidase inhibitors based on xanthones: A closer look into the structure-activity correlations. Eur J Med Chem. 2011, 46: 4050-4055. 10.1016\/j.ejmech.2011.06.003.","journal-title":"Eur J Med Chem"},{"key":"620_CR24","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1021\/jm9810046","volume":"41","author":"A Rampa","year":"1998","unstructured":"Rampa A, Bisi A, Valenti P, Recanatini M, Cavalli A, Andrisano V, Cavrini V, Fin L, Buriani A, Giusti P: Acetylcholinesterase inhibitors: Synthesis and structure-activity relationships of \u03c9-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxy heteroaryl derivatives. J Med Chem. 1998, 41: 3976-3986. 10.1021\/jm9810046.","journal-title":"J Med Chem"},{"key":"620_CR25","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1021\/jm049515h","volume":"48","author":"F Belluti","year":"2005","unstructured":"Belluti F, Rampa A, Piazzi L, Bisi A, Gobbi S, Bartolini M, Andrisano V, Cavalli A, Recanatini M, Valenti P: Cholinesterase inhibitors: Xanthostigmine derivatives blocking the acetylcholinesterase -induced \u03b2-amyloid aggregation. J Med Chem. 2005, 48: 4444-4456. 10.1021\/jm049515h.","journal-title":"J Med Chem"},{"key":"620_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.bmc.2006.09.026","volume":"15","author":"L Piazzi","year":"2007","unstructured":"Piazzi L, Belluti F, Bisi A, Gobbi S, Rizzo S, Bartolini M, Andrisano V, Recanatini M, Rampa A: Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[\u03c9-(benzylmethylamino)alkoxy] xanthen-9-ones. Bioorgan Med Chem. 2007, 15: 575-585. 10.1016\/j.bmc.2006.09.026.","journal-title":"Bioorgan Med Chem"},{"key":"620_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cbi.2009.06.024","volume":"181","author":"MTH Khan","year":"2009","unstructured":"Khan MTH, Orhan I, Senol FS, Kartal M, Sener B, Dvorsk\u00e1 M, Smejkal K, Slapetov\u00e1 T: Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studies. Chem-Biol Interact. 2009, 181: 383-389. 10.1016\/j.cbi.2009.06.024.","journal-title":"Chem-Biol Interact"},{"key":"620_CR28","doi-asserted-by":"publisher","first-page":"6919","DOI":"10.1016\/j.bmc.2012.10.015","volume":"20","author":"GL Nian","year":"2012","unstructured":"Nian GL, Shu LS, Min ZS, Yu PT, Zhi HS, Hao T, Qian PS, Yi FF, Jian AD: Mannich bases of Scutellarein as thrombin-inhibitors: Design, synthesis, biological activity and solubility. Bioorgan Med Chem. 2012, 20: 6919-6923. 10.1016\/j.bmc.2012.10.015.","journal-title":"Bioorgan Med Chem"},{"key":"620_CR29","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1016\/j.bmc.2007.02.030","volume":"15","author":"Y Liu","year":"2007","unstructured":"Liu Y, Ma L, Chen WH, Wang B, Xu ZL: Synthesis of xanthone derivatives with extended \u03c0-systems as \u03b1-glucosidase inhibitors: Insight into the probable binding mode. Bioorgan Med Chem. 2007, 15: 2810-2814. 10.1016\/j.bmc.2007.02.030.","journal-title":"Bioorgan Med Chem"},{"key":"620_CR30","first-page":"3982","volume-title":"J Chem Soc","author":"PK Grover","year":"1955","unstructured":"Grover PK, Shah GD, Shah RC: Xanthones. IV. A new synthesis of hydroxyxanthones and hydroxybenzophenones. J Chem Soc. 1955, 3982-3985."},{"key":"620_CR31","doi-asserted-by":"publisher","first-page":"7358","DOI":"10.1016\/j.bmc.2008.06.018","volume":"16","author":"MVB Reddy","year":"2008","unstructured":"Reddy MVB, Su CR, Chiou WF, Liu YN, Chen RYH, Bastow KF, Lee KH, Wu TS: Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents. Bioorgan Med Chem. 2008, 16: 7358-7370. 10.1016\/j.bmc.2008.06.018.","journal-title":"Bioorgan Med Chem"},{"key":"620_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.bmc.2006.09.055","volume":"15","author":"A Chipeleme","year":"2007","unstructured":"Chipeleme A, Gut J, Rosenthalb PJ, Chibale K: Synthesis and biological evaluation of phenolic Mannich bases of benzaldehyde and (thio)semicarbazone derivatives against the cysteine protease falcipain-2 and a chloroquine resistant strain of Plasmodium falciparum. Bioorgan Med Chem. 2007, 15: 273-282. 10.1016\/j.bmc.2006.09.055.","journal-title":"Bioorgan Med Chem"},{"key":"620_CR33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/BF02236285","volume":"35","author":"LA Kintsurashvili","year":"1999","unstructured":"Kintsurashvili LA, Sikharulidze MI, Buyanov VN, Turabelidze DG: Synthesis of amino derivatives of 1,6,8-trihydroxy-3-methyl-9,10-anthraquinone. Chem Nat Compd. 1999, 35: 619-620. 10.1007\/BF02236285.","journal-title":"Chem Nat Compd"},{"key":"620_CR34","first-page":"197","volume-title":"Structure Determination of Organic Compounds Table of Spectral Data","author":"E Pretsch","year":"2002","unstructured":"Pretsch E, B\u00fchlmann P, Affolter C: Structure Determination of Organic Compounds Table of Spectral Data. Edited by: Rong GB, Zhu SZ. 2002, Shanghai, East China: University of Science and Technology Press, 197-in Chinese"},{"key":"620_CR35","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/mrc.1270091106","volume":"9","author":"PW Westerman","year":"1977","unstructured":"Westerman PW, Gunasekera SP, Uvais M, Sultanbawa S, Kazlauskas R: Carbon -13 NMR study of naturally occurring xanthones. Org Magn Reson. 1977, 9: 631-636. 10.1002\/mrc.1270091106.","journal-title":"Org Magn Reson"},{"key":"620_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres VJ, Featherstone RM: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961, 7: 88-95. 10.1016\/0006-2952(61)90145-9.","journal-title":"Biochem Pharmacol"},{"key":"620_CR37","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1021\/jm070100g","volume":"50","author":"L Piazzi","year":"2007","unstructured":"Piazzi L, Cavalli A, Belluti F, Bisi A, Gobbi S, Rizzo S, Bartolini M, Andrisano V, Recanatini M, Rampa A: Extensive SAR and computational studies of 3-{4-[(Benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone(AP2238) derivatives. J Med Chem. 2007, 50: 4250-4254. 10.1021\/jm070100g.","journal-title":"J Med Chem"},{"key":"620_CR38","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.1021\/jm800277g","volume":"51","author":"E Rivera-Becerril","year":"2008","unstructured":"Rivera-Becerril E, Joseph-Nathan P, P\u00e9rez-\u00c1lvarez VM, Morales-R\u00edos MS: Synthesis and biological evaluation of (-)- and (+)- Debromoflustramine B and its analogues as selective butyrylcholinesterase inhibitors. J Med Chem. 2008, 51: 5271-5284. 10.1021\/jm800277g.","journal-title":"J Med Chem"},{"key":"620_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1021\/bi00052a003","volume":"32","author":"DC Vellom","year":"1993","unstructured":"Vellom DC, Radic\u2032 Z, Li Y, Pickering NA, Camp S, Taylor P: Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity. Biochemistry. 1993, 32: 12-17. 10.1021\/bi00052a003.","journal-title":"Biochemistry"},{"key":"620_CR40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1432-1033.1996.00036.x","volume":"235","author":"P Masson","year":"1996","unstructured":"Masson P, Froment MT, Bartels CF, Lockridge O: Asp70 in the peripheral anionic site of human butyrylchilinesterase. Eur J Biochem. 1996, 235: 36-48. 10.1111\/j.1432-1033.1996.00036.x.","journal-title":"Eur J Biochem"},{"key":"620_CR41","doi-asserted-by":"publisher","first-page":"41141","DOI":"10.1074\/jbc.M210241200","volume":"278","author":"Y Nicolet","year":"2003","unstructured":"Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps JC, Nachon F: Crystal structure of human butyrylcholinesterase and of its complexe with substrate and products. J Biol Chem. 2003, 278: 41141-41147. 10.1074\/jbc.M210241200.","journal-title":"J Biol Chem"},{"key":"620_CR42","doi-asserted-by":"publisher","first-page":"10827","DOI":"10.1073\/pnas.89.22.10827","volume":"89","author":"M Harel","year":"1992","unstructured":"Harel M, Sussman JL, Krejci E, Bon S, Chanal P, Massoulie J, Silman I: Conversion of acetylcholinesterase to butyrylcholinesterase: Modeling and mutagenesis. Proc Natl Acad Sci USA. 1992, 89: 10827-10831. 10.1073\/pnas.89.22.10827.","journal-title":"Proc Natl Acad Sci USA"},{"key":"620_CR43","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/pro.5560020309","volume":"2","author":"M Cygler","year":"1993","unstructured":"Cygler M, Schrag JD, Sussman JL, Harel M, Silman I, Gentry MK, Doctor BP: Relationship between sequence conservation and three-dimensional structure in a large family of esterases, lipases, and related proteins. Protein Sci. 1993, 2: 366-382.","journal-title":"Protein Sci"},{"key":"620_CR44","doi-asserted-by":"publisher","first-page":"7433","DOI":"10.1021\/bi010181x","volume":"40","author":"D Kaplan","year":"2001","unstructured":"Kaplan D, Ordentlich A, Barak D, Ariel N, Kronman C, Velan B, Shafferman A: Does \u201cbutyryllization\u201d of acetylcholinesterase through substitution of the six divergent aromatic amino acids in the active center gorge generate an enzyme mimic of butyrylcholinesterase?. Biochemistry. 2001, 40: 7433-7445. 10.1021\/bi010181x.","journal-title":"Biochemistry"}],"container-title":["Chemistry Central Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-153X-7-78.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T10:49:23Z","timestamp":1576666163000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/1752-153X-7-78"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,27]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["620"],"URL":"https:\/\/doi.org\/10.1186\/1752-153x-7-78","relation":{},"ISSN":["1752-153X"],"issn-type":[{"value":"1752-153X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,27]]},"article-number":"78"}}